Medtronic taps top digital and healthcare technology leaders to drive business transformation

Four external appointments include a new digital innovation leader, a head of global strategy and two business unit president positions within the neuroscience portfolio

DUBLIN, November 15, 2021 /PRNewswire/ — Medtronic plc (NYSE: MDT) today announced four leadership appointments to continue its commitment to becoming the global health technology leader.

Mira Sahney

  • Bob HopkinsHead of Global Strategy, effective immediately.

  • Mei-Jiangnew world leader in digital innovation, effective today.

  • Harry “Jump” KiilPresident of the Cranial and Spinal Technologies (CST) Business Unit, workforce January 4, 2022.

  • Mira SahneyPresident of the Pelvic Health Operational Unit, workforce December 6, 2021.

“We are taking bold steps to lead in health technology and be a destination for world-class talent,” said Geoff Martha, Chairman and CEO of Medtronic. “These leadership appointments bring outside thinking, new skills and capabilities, and diverse perspectives to our already talented leadership team – and will continue to fuel Medtronic’s transformation.

Bob Hopkinshead of global strategy
Hopkins will join as head of global strategy. Hopkins joins from Bank of America Merrill Lynch, where he has served as a managing director since 2008, covering the medical technology industry, including Medtronic. Hopkins has worked with the medical technology industry for over 25 years. He has been the top industry analyst for the past three years in Institutional Investor’s annual survey and has ranked in the top three for the past 17 years.

In his role, Hopkins will partner with senior Medtronic management in the areas of strategy, business development, capital deployment and investor communications. Its broad global perspective, including insights into companies, technologies and trends impacting the healthcare and medtech industry, will help Medtronic continue to navigate the rapidly changing industry.

Mei-Jianghead of global digital innovation
Jiang will join Medtronic from Iron Mountain, where she served as senior vice president, global head of innovation, products and solutions.

Prior to Iron Mountain, Jiang spent six years at HP, where she most recently served as Head of Digital Innovation and Business Transformation, and at Cisco, where she was Founder/CEO of a consulting startup. management. Since 2000, she has led three startups to accelerated growth and has served on several Silicon Valley startup boards.

Jiang is also a member of the Forbes Technology Council and a founding member of “Chief”; a private network designed for female leaders – rising from VP to CEO level – to build their C-suite experience.

In his new role, Jiang will work with leaders across the organization to test, develop and accelerate Medtronic’s data, digitalization and AI strategies globally. This work includes using data and AI to improve internal processes, as well as establishing new business models leveraging existing capabilities and technologies. It will transform core business markets and businesses using insights from data and AI, and establish the capabilities and resources required across the enterprise to support this transformation.

Harry “Skip” Kiil, President, Cranial and Spinal Technologies Business Unit
Kiil will join Medtronic from Smith+Nephew, where he was president of the global orthopedics business, responsible for the company’s reconstructive joint replacement, robotics, trauma and extremities businesses. Kiil has extensive experience in the field of spine and orthopedics, a deep understanding of international markets, and expertise in leveraging technology to create and deliver an integrated ecosystem at scale.

Previously, Kiil was Executive Vice President and President of Global Business Operations at NuVasive, Inc. He also served as Chief of Surgery, Europe, Middle East, Africaand Russia, in the Alcon Eye Care division of Novartis Corporation, where he was responsible for leading the commercial transformation of the surgical business in developed and emerging growth markets. Prior to joining Alcon, Kiil spent 12 years with Stryker Corporation, where he held several leadership positions, including Vice President and General Manager of Europeand general manager of Japan.

In his new role, Kiil will be responsible for driving innovation and delivering therapies to markets around the world faster and more efficiently and cultivating a strong culture within Cranial and Spinal Technologies.

Mira SahneyChair, Pelvic Health Business Unit
Sahney brings over 25 years of leadership experience in the development and commercialization of innovative medical technologies in the fields of gynecology, ENT, orthopedics and medical robotics. Sahney will draw on his extensive experience in mergers and acquisitions, product marketing and business strategy to lead the Pelvic Health business unit into the increasingly competitive future of the incontinence market.

Sahney joins Medtronic from Hyalex Orthopedics, a medical device startup based in Lexington, MA — where she has served as CEO and board member since 2017. In this role, she formed her investment syndicate and built a world-class organization.

Prior to Hyalex, Sahney held several leadership positions at Smith+Nephew, including Senior Vice President and General Manager of ENT and Gynecology. She also led the sale of Smith+Nephew’s gynecology business to Medtronic in 2016.

Prior to her tenure at Smith + Nephew, Sahney was President, CEO and Co-Founder of Myomo, Inc., an award-winning medical robotics startup that went public in 2017. Her early career included a variety of supply chains, d engineering, strategy, product management, product development, research and software at Flow International, BMW Group and Boeing.

In her new role, Sahney will be responsible for driving innovation and expanding access to more patients around the world, while cultivating a strong culture within Pelvic Health.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the global health technology leader boldly tackling the toughest health challenges facing humanity by researching and finding solutions. Our mission – to relieve pain, restore health and extend life – brings together a global team of more than 90,000 passionate people in 150 countries. Our technologies and therapies address 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. With our diverse knowledge, insatiable curiosity, and desire to help everyone in need, we deliver innovative technologies that transform two people’s lives every second, every hour, every day. Expect more from us as we deliver insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we design the extraordinary. For more information about Medtronic (NYSE:MDT), visit and follow @Medtronic on Twitter and LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports filed with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.


Erika Winkels

Ryan Weispfenning

Public relations

Investor Relations



Harry “Pass” Kiil

Harry “Jump” Kiil

Bob Hopkins

Bob Hopkins



(PRNewsfoto/Medtronic plc)

(PRNewsfoto/Medtronic plc)



View original content for multimedia download:

SOURCEMedtronic plc

Comments are closed.